HODGKINS-DISEASE - VALUE OF PROGNOSTIC CRITERIA AND OF COMBINATION OF RADIOTHERAPY AND CHEMOTHERAPY IN LOCALIZED LYMPHOID STAGE-1 AND STAGE-II - 94 PATIENTS UNDERGOING LAPAROTOMY

被引：0

|

作者：

BERNADOU, A

BLANC, CM

JAMES, JM

DAO, C

ZITTOUN, R

BILSKIPASQUIER, G

机构：

来源：

NOUVELLE PRESSE MEDICALE | 1978年 / 7卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：807 / 812

页数：6

相关论文

共 50 条

[21] COMBINATION CHEMOTHERAPY LOW DOSE RADIOTHERAPY FOR STAGE III-B AND IV HODGKINS-DISEASE
FARBER, LR
PROSNITZ, LR
DECONTI, RC
BERTINO, JR
FISCHER, JJ
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 266 - 266
[22] RADIOTHERAPY VERSUS RADIOTHERAPY PLUS CHEMOTHERAPY IN STAGE-I AND STAGE-II HODGKINS-DISEASE - A PROSPECTIVE, RANDOMIZED STUDY BY THE DANISH-NATIONAL-HODGKIN-STUDY-GROUP, LYGRA
NISSEN, NI
NORDENTOFT, AM
BRINCKER, H
ANDERSEN, E
JENSEN, MK
NIELSEN, JB
PEDERSENBJERGAARD, J
JENSEN, TS
JENSEN, KB
VIDEBAEK, A
PEDERSEN, M
WALBOMJORGENSEN, S
SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1980, 25 (01): : 35 - 44
[23] PROGNOSTIC FACTORS FOR PATIENTS RELAPSING AFTER RADIOTHERAPY FOR EARLY-STAGE HODGKINS-DISEASE
ROACH, M
BROPHY, N
COX, R
VARGHESE, A
HOPPE, RT
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) : 623 - 629
[24] TREATMENT OF HODGKINS-DISEASE, CLINICAL STAGE 1 AND CLINICAL STAGE 2 - RESULTS OBTAINED IN 100 PATIENTS BY COMBINED CHEMOTHERAPY AND RADIOTHERAPY
LAGARDE, C
CHAUVERGNE, J
HOERNI, B
TOUCHARD, J
DURAND, M
HOERNISIMON, G
BRUNET, R
ACTA HAEMATOLOGICA, 1976, 55 (05) : 257 - 264
[25] PATTERNS OF RELAPSE IN LOCALIZED (STAGE-1 AND STAGE-2) HODGKINS-DISEASE (HD) FOLLOWING EXTENDED FIELD RADIOTHERAPY (EFXRT) VS INVOLVED FIELD RADIOTHERAPY (IFXRT) PLUS MOPP
COLTMAN, CA
FULLER, LM
BLOOD, 1977, 50 (05) : 188 - 188
[26] COMBINATION CHEMOTHERAPY-RADIOTHERAPY FOR STAGE III HODGKINS-DISEASE - AN ACUTE LEUKEMIA GROUP B STUDY
HOOGSTRATEN, B
HOLLAND, JF
KRAMER, S
GLIDEWELL, OJ
ARCHIVES OF INTERNAL MEDICINE, 1973, 131 (03) : 424 - 428
[27] THE EFFICIENCY OF DIFFERENT COMBINED TREATMENT PROGRAMS (COMBINATION CHEMOTHERAPY-RADIOTHERAPY) USED FOR STAGE-I-II HODGKINS-DISEASE
BAYSOGOLOV, GD
SHAKHTARINA, SV
RADIOTHERAPY AND ONCOLOGY, 1987, 8 (02) : 113 - 122
[28] IS STAGING LAPAROTOMY OF THERAPEUTIC VALUE IN PATIENTS WITH SUPRADIAPHRAGMATIC HODGKINS-DISEASE, CLINICAL STAGE IA-IIA
ABRAHAMSEN, AF
HOST, H
JORGENSEN, OG
SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1980, 25 (05): : 439 - 444
[29] INDIVIDUAL RISK OF ABDOMINAL DISEASE IN PATIENTS WITH STAGE-I AND STAGE-II SUPRADIAPHRAGMATIC HODGKINS-DISEASE - A RULE INDEX BASED ON 341 LAPAROTOMIZED PATIENTS
DELACRUZ, GA
CARDENES, H
OTERO, J
MILLAN, I
DELATORRE, A
POLO, E
VALCARCEL, F
PAREDES, MC
CANCER, 1989, 63 (09) : 1799 - 1803
[30] PROGNOSTIC FACTORS OF STAGE-I AND STAGE-II NON-HODGKINS LYMPHOMAS OF THE HEAD AND NECK - THE VALUE OF THE WORKING FORMULATION AND NEED FOR CHEMOTHERAPY
SHIGEMATSU, N
KONDO, M
MIKATA, A
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (05): : 1111 - 1118

← 1 2 3 4 5 →